CLINICAL_TRIALS
trial_result
· 2016-10-14
Clinical Trial Update: Safety, Blood Levels and Effects of AUT00206 [Phase 1]
Summary
Phase 1 study evaluating the safety, pharmacokinetics (blood levels), and pharmacodynamic effects of AUT00206 in schizophrenia; the trial has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Autifony Therapeutics Limited | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED